Hashizume S
Gan To Kagaku Ryoho. 1984 Jun;11(6):1296-302.
The effects of Human Lymphoblastoid Interferon ( HLBI ) on the growth of 2 human malignant melanoma xenografts in nude mice were investigated. At a dose of 6 X 10(5) IU, the growth of SK-14 was significantly inhibited by intratumoral administration, whereas that of AM-1 was only moderately by inhibited. Tumor cell of SK-14 was found to be degenerated and replaced with melanophages by histological observation, while that of AM-1 showed no significant changes. Dose response of the inhibitory effect of HLBI (6 X 10(5)IU, 1 X 10(5)IU) was investigated against tumor cell of SK-14. At a dose of 6 X 10(5)IU, the growth was strongly inhibited, whereas 1 X 10(5)IU showed only a moderate effect. In conclusion, the sensitivity of malignant melanoma xenograft to the inhibitory effect of HLBI varied with the cell line. It was considered that a relative large dose of HLBI was necessary for an appreciable effect on the malignant melanoma xenograft.
研究了人淋巴母细胞干扰素(HLBI)对裸鼠体内2种人恶性黑色素瘤异种移植瘤生长的影响。在剂量为6×10⁵国际单位时,瘤内注射可显著抑制SK - 14的生长,而对AM - 1的生长仅产生中度抑制。组织学观察发现,SK - 14的肿瘤细胞发生退变并被噬黑素细胞取代,而AM - 1的肿瘤细胞未见明显变化。研究了HLBI(6×10⁵国际单位、1×10⁵国际单位)对SK - 14肿瘤细胞抑制作用的剂量反应。在剂量为6×10⁵国际单位时,生长受到强烈抑制,而1×10⁵国际单位仅显示中度作用。总之,恶性黑色素瘤异种移植瘤对HLBI抑制作用的敏感性因细胞系而异。认为需要相对大剂量的HLBI才能对恶性黑色素瘤异种移植瘤产生明显作用。